Drug ID: | NPD3136 |
Drug Name: | CMS-024 |
Molecular Formula: | C18H27N3O6 |
Canonical SMILES: | OC[C@@H](C(=N[C@H](C(=O)O)CC(C)C)O)N=C([C@H](Cc1ccc(cc1)O)N)O |
Standard InCHI: | InChI=1S/C18H27N3O6/c1-10(2)7-14(18(26)27)20-17(25)15(9-22)21-16(24)13(19)8-11-3-5-12(23)6-4-11/h3-6,10,13-15,22-23H,7-9,19H2,1-2H3,(H,20,25)(H,21,24)(H,26,27)/t13-,14-,15-/m0/s1 |
Standard InCHIKey: | MQGGXGKQSVEQHR-KKUMJFAQSA-N |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB011044 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 381.19 |
ALogP | -1.6423 |
MLogP | 2.45 |
XLogP | -1.518 |
HDA | 8 |
HBD | 6 |
Rotatable Bonds | 18 |
TPSA | 168.96 |
RO5 Violation | 1 |